Lineage Cell Therapeutics, Inc.LCTXNYSE
LOADING
|||
Switch Symbol:
Gross Profit Growth Recovery in Progress
Trending higher, below historical average, structural decline.
Left:
||||
Year-over-year gross profit growth rate
Latest
10.77%
↓ 88% below average
Average (9y)
92.02%
Historical baseline
Range
High:536.60%
Low:-63.60%
CAGR
-10.3%
Structural decline
| Period | Value |
|---|---|
| 2024 | 10.77% |
| 2023 | -40.79% |
| 2022 | 465.79% |
| 2021 | 536.60% |
| 2020 | -63.60% |
| 2019 | -4.31% |
| 2018 | -31.40% |
| 2017 | -14.26% |
| 2016 | 32.73% |
| 2015 | 28.64% |